Our study revealed that the expression of CAP1 mRNA was increased in various cell subsets, including B cells, CD16+ monocytes, erythroid lineages, plasma cells, HSPCs, and other cell subsets, in patients with ITP (Figure 5D; Figure S7F, Supporting Information). The gene discussed is FCGR3A; the disease is autoimmune thrombocytopenic purpura.